These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 4396845

  • 1. [Changes in the electrocardiographic pattern after exercise in patients with coronary disease following administration of beta-blocking agents].
    Sala G, Foresti A, Campolo L.
    Minerva Cardioangiol; 1969 Oct; 17(10):759-67. PubMed ID: 4396845
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of beta adrenergic blockaders on the effort test in coronary insufficiency].
    Demiroglu C, Oztürk M.
    Presse Med (1893); 1971 Apr 03; 79(17):765-6. PubMed ID: 4396515
    [No Abstract] [Full Text] [Related]

  • 3. [Immediate effect of beta-blockaders on coronary patients during exertion].
    Vastesaeger MM, Rasson G.
    Brux Med; 1971 Jun 03; 51(6):429-36. PubMed ID: 4397872
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E.
    Clin Ter; 1970 May 31; 53(4):315-21. PubMed ID: 4394192
    [No Abstract] [Full Text] [Related]

  • 5. [Protective effect of a beta-blockador on clinico-electrocardiographic manifestations in the coronary insufficiency apparent during Master's test: description of a clinical case].
    Conti G, Piemontese M, Savarese A, Valva M.
    Clin Ter; 1969 Apr 30; 49(2):181-7. PubMed ID: 4401859
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of the exercise test on changes of repolarization present in the resting electrocardiogram].
    Nazzari E, Griffo R, Bertolotti MC, Caponnetto S.
    Minerva Cardioangiol; 1979 Apr 30; 27(7-8):445-54. PubMed ID: 44897
    [No Abstract] [Full Text] [Related]

  • 7. Should beta-blockers be withdrawn in post-myocardial infarction patients before treadmill test?
    Wander GS, Pasricha S, Aslam N, Avasthi G, Mahajan R, Khurana SB.
    Indian Heart J; 1997 Apr 30; 49(5):503-6. PubMed ID: 9505017
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR, Zanacchi G.
    Minerva Cardioangiol; 1971 Mar 30; 19(3):160-71. PubMed ID: 4396512
    [No Abstract] [Full Text] [Related]

  • 9. [A new beta-receptor blockader as anti-arrhythmic agent].
    Dahlberg A.
    Lakartidningen; 1972 Mar 15; 69(12):1334-5. PubMed ID: 4402107
    [No Abstract] [Full Text] [Related]

  • 10. LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias.
    Storstein L.
    Acta Med Scand; 1972 May 15; 191(5):423-8. PubMed ID: 4402323
    [No Abstract] [Full Text] [Related]

  • 11. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients].
    Saner R.
    Therapie; 1970 May 15; 25(2):393-501. PubMed ID: 4403159
    [No Abstract] [Full Text] [Related]

  • 12. [Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
    Staszewska-Barczak J.
    Acta Physiol Pol; 1970 May 15; 21(3):317-29. PubMed ID: 4393011
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct].
    De Ambroggi L, Perotta GM, Satolli R, Lotto A.
    Boll Soc Ital Cardiol; 1977 May 15; 22(8):1343-51. PubMed ID: 36116
    [No Abstract] [Full Text] [Related]

  • 14. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A, Klein G, Himmler FC, Schmidt G.
    Herz; 1981 Apr 15; 6(2):73-83. PubMed ID: 6112196
    [Abstract] [Full Text] [Related]

  • 15. [Clinical testing of a new combination product of a beta blocking agent and a nitroderivative].
    Melli A, Malagù I, Golinelli G, Soffritti A.
    Minerva Med; 1970 Sep 29; 61(78):4271-8. PubMed ID: 4397054
    [No Abstract] [Full Text] [Related]

  • 16. Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
    Fehrenbach SN, Budnitz DS, Gazmararian JA, Krumholz HM.
    Am J Manag Care; 2001 Jul 29; 7(7):717-23. PubMed ID: 11464429
    [Abstract] [Full Text] [Related]

  • 17. [Diagnosis of ischemia and survival after myocardial infarction using perfusion scintigraphy with exercise thallium-201. Relationship with electrocardiographic and angiographic findings].
    Ventosa A, Gil V, Seabra-Gomes R.
    Rev Port Cardiol; 1995 Feb 29; 14(2):123-35, 104. PubMed ID: 7766436
    [Abstract] [Full Text] [Related]

  • 18. [Silent myocardial ischemia. Arguments against treatment].
    Rayo Llerena I, Marín Huerta E.
    Rev Esp Cardiol; 1996 Jan 29; 49(1):6-12. PubMed ID: 8685514
    [No Abstract] [Full Text] [Related]

  • 19. The effect of a new beta blocking drug (butidrine) on some biohumoral indices, liver and kidney function and exercise tolerance.
    Barbi G, Tallone B.
    Panminerva Med; 1969 Jan 29; 11(7):372-7. PubMed ID: 4390702
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K.
    Z Arztl Fortbild (Jena); 1970 Jul 29; 64(13):671-3. PubMed ID: 4398819
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.